Why brokers give the Ramsay Health (ASX:RHC) share price a thumbs up

Although the Ramsay share price has been volatile of late, brokers seem to see plenty of upside. Here's why.

Ramsay Health Care Limited (ASX: RHC) share price has been on a rollercoaster ride recently.

Shares in the health care company reached a high of $69.49 in November only to fall as low as $58.71 in January. At the time of writing, the Ramsay Health share is trading at $63.66, up 2.22%.

Despite the volatility, it appears that brokers are positive about the future of the company. We take a look at some of the reasons why. 

positive asx share price represented by lots of hands all making thumbs up gesture

Image source: Getty Images

A major acquisition

Ramsay Health Care announced last month that it was putting a cash offer to acquire the UK-based Spire Group. Spire is an independent hospital group focused on the private patient market and a leading provider of high-acuity care.

The UK acquisition appears to be a logical step for Australia's largest private hospital provider.

As described in its company literature, Ramsay "provides quality health care through a global network of clinical practice, teaching and research". The company says its global network extends across 10 countries, with more than eight million admissions/patient visits to its facilities in more than 460 locations.

Which brokers are positive on the company?

Citi Bank yesterday upgraded Ramsay Health Care to a buy.  The broker attributed to rating upgrade to the recent fall in the Ramsay share price and the fact that company has underperformed the ASX 200 by 14% in the last quarter. 

Citi expects an big upside with the Spire acquisition, COVID-19 restrictions being lifted and hospitals getting back to normal.

Analysts at Macquarie are also positive about the healthcare company.  Macquarie has retained its outperform rating and $74.85 price target on Ramsay Health Care.

Macquarie believes that the Spire deal stems well for the Ramsay share price and long term growth in the lucrative UK market.

With the Ramsay share price currently trading around $63, Macquarie's price target is a whopping 20% upgrade on the current price.

.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A woman looks nonplussed as she holds up a handful of Australian $50 notes.
Healthcare Shares

At $199, are CSL shares a bargain buy or a risky investment?

Here's my verdict on the ASX biotech stock.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Falling pills in a blue background.
Healthcare Shares

Mayne shares are up 80% on takeover news, but there's still money to be made

Major shareholders are backing the deal in.

Read more »

Male and female scientists analysing data on a computer.
Healthcare Shares

Why I'd buy this ASX biotechnology company over CSL

The potential for research-driven growth could be large.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Neuren Pharmaceuticals shares just hit a 12-month high. There could be more good news to come

This week's sales figures were impressive.

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

Do I still rate CSL shares as a buy after rising 120% in four months?

Let's see if it is too late to buy this biotech giant's shares.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Healthcare Shares

CSL shares push past $200: Is $250 next?

How much further can the CSL share price rally go?

Read more »

Woman holding her glasses and looking at her laptop.
Healthcare Shares

ResMed or Cochlear: Which ASX healthcare share would I buy today?

I like both businesses for the long term, but their recent financial performances have given me something to think about.

Read more »